Mereo BioPharma Group plc
Ticker: 1719714
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2025 | Q2 FY2023 |
|---|---|---|
| INCOME | ||
| Revenue | 0.50-94.4% | 9.00 |
| Total Income | 0.50-94.4% | 9.00 |
| EXPENSES | ||
| Expenditure | 11.00+12.1% | 9.81 |
| Tax | 0.00 | 0.00 |
| PROFIT | ||
| PBT | -14.62-735.4% | -1.75 |
| Net Profit | -14.62-735.4% | -1.75 |
| KEY METRICS | ||
| OPM % | -100.00%-90.99pp | -9.01% |
| NPM % | -100.00%-80.54pp | -19.46% |
| EPS | -0.02 | 0.00 |
Corporate Events
Board MeetingMREO
202614May
Board Meeting
Results of the 2026 Annual General Meeting, including the re…
SEC Filing ↗